|
|
|
Volumn 27, Issue 2, 2002, Pages 127-139
|
|
Tamoxifen, raloxifene and the prevention of breast cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ESTROGEN;
ESTROGEN RECEPTOR;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
ADULT;
ANIMAL;
BREAST TUMOR;
CARCINOMA;
CHEMICALLY INDUCED DISORDER;
CHEMISTRY;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DRUG DESIGN;
DRUG EFFECT;
ENDOMETRIUM TUMOR;
EXPERIMENTAL NEOPLASM;
FEMALE;
HUMAN;
INCIDENCE;
MIDDLE AGED;
MULTICENTER STUDY;
NEOPLASM;
OSTEOPOROSIS;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
STRUCTURE ACTIVITY RELATION;
ADULT;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CARCINOMA;
CORONARY DISEASE;
DRUG DESIGN;
ENDOMETRIAL NEOPLASMS;
ESTROGENS;
FEMALE;
HUMANS;
INCIDENCE;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MIDDLE AGED;
MULTICENTER STUDIES;
NEOPLASMS, HORMONE-DEPENDENT;
OSTEOPOROSIS;
PROSPECTIVE STUDIES;
RALOXIFENE;
RANDOMIZED CONTROLLED TRIALS;
RECEPTORS, ESTROGEN;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
TAMOXIFEN;
|
|
EID: 0036615832
PISSN: 03911977
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (18)
|
|
References (107)
|
